A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret prostate-specific antigen (PSA) test results compared to existing models. The tool, tested on over 200,000 men,…
Continue Reading
News Source: medicalxpress.com
Leave a Reply